Skip to main content

Table 1 Demographics of patients with chordoma

From: C-reactive protein as a prognostic factor in patients with chordoma of lumbar spine and sacrum—a single center pilot study

Number

Sex

Age (years)

Histology

Tumor site

Follow-up

Death of disease

CRP (mg/dl)

Confounding diagnosis

        

Tumor

CVD

1

Male

68

Conventional

Prox S3

2.7

No

0.81

 

Hypertensive heart insufficiency II, Hyperlipidemia

2

Male

85

Conventional

Distal S3

11.1

No

0.10

 

Hypertension

3

Male

52

Conventional

Distal S3

6.3

No

0.22

 

Hypertension

4

Male

79

Conventional

Distal S3

3.7

No

0.85

 

Hypertension, type II diabetes, obesity

5

Male

81

Conventional

Distal S3

2.8

No

1.18

Prostataca

 

6

Female

81

Conventional

Distal S3

6.0

No

2.24

  

7

Female

79

Conventional

Distal S3

1.4

Yes

0.87

  

8

Male

71

Conventional

Prox S3

8.9

No

0.40

  

9

Male

82

Conventional

Distal S3

1.6

Yes

0.00

  

10

Male

58

Chondroid

Distal S3

4.2

No

0.40

 

Hypertension, hyperlipidemia

11

Male

84

Conventional

Distal S3

4.1

Yes

1.10

  

12

Male

56

Chondroid

Prox S3

8.1

No

0.15

 

Hypertension, obesity

13

Male

73

Conventional

Prox S3

2.1

No

0.70

  

14

Male

35

Conventional

Distal S3

1.6

Yes

0.90

  

15

Female

66

Conventional

Prox S3

3.6

No

0.58

  

16

Male

62

Conventional

Prox S3

4.3

No

3.30

  

17

Male

62

Conventional

Prox S3

3.0

Yes

3.10

  

18

Male

20

Conventional

Distal S3

0.5

Yes

0.81

  

19

Female

77

Conventional

Prox S3

16.5

No

1.32

Basalioma

 

20

Female

77

Chondroid

Prox S3

3.0

Yes

0.14

  

21

Male

60

Conventional

Distal S3

18.8

No

1.95

 

Hypertension

22

Female

68

Dedifferentiated

Prox S3

4.4

Yes

0.20

  

23

Male

52

Conventional

Distal S3

2.1

No

7.60

 

Hypertension, renal insufficiency, chon. Prostatitis

24

Male

77

Conventional

Distal S3

1.3

Yes

8

  
  1. Tumors (additional tumors)
  2. CVD cardiovascular disease (meant to be confounders of increased CRP)